<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SWTX
SpringWorks Therapeutics
$
()


  • SpringWorks Therapeutics price target raised to $74 from $73 at JPMorgan

    3/6/2024 - 06:08am
  • SpringWorks Therapeutics submits rolling NDA to FDA for mirdametinib

    3/4/2024 - 06:40am
  • SpringWorks Therapeutics announces EMA validaion for nirogacestat MAA

    2/29/2024 - 08:41am
  • SpringWorks Therapeutics price target raised by $16 at Barclays, here's why

    2/29/2024 - 06:44am
  • SpringWorks Therapeutics price target raised by $5 at Goldman Sachs, here's why

    2/27/2024 - 17:19pm
  • SpringWorks Therapeutics reports Q4 EPS ($1.44), consensus ($1.24)

    2/27/2024 - 06:33am
  • SpringWorks Therapeutics price target raised by $10 at Wedbush, here's why

    2/26/2024 - 07:43am
  • SpringWorks Therapeutics price target raised by $6 at Barclays, here's why

    1/25/2024 - 05:40am
  • JPMorgan ups SpringWorks target, adds to Analyst Focus List

    1/17/2024 - 07:40am
  • Goldman Sachs pharmaceuticals analysts hold an analyst/industry conference call

    12/8/2023 - 11:18am
  • SpringWorks Therapeutics 9.483M share Spot Secondary priced at $29.00

    12/5/2023 - 06:42am
  • Fly Intel: After-Hours Movers

    12/4/2023 - 18:39pm
  • SpringWorks Therapeutics $250M Spot Secondary; price range $28.80-$30.00

    12/4/2023 - 16:22pm
  • SpringWorks Therapeutics announces $250M common stock offering

    12/4/2023 - 16:15pm
  • Biotech Alert: Searches spiking for these stocks today

    12/1/2023 - 10:56am
dynamic_feed Breaking News